TARSUS PHARMACEUTICALS INC (TARS) Stock Cash Flow
NASDAQ:TARS - Nasdaq - US87650L1035 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -104.94M | -115.55M | -135.89M | -62.09M | -13.83M | |||
| Depreciation Amortization | 1.42M | 1.23M | 877.00K | 330.00K | 310.00K | |||
| Change In Working Capital | 10.52M | 3.84M | 306.00K | -950.00K | 1.37M | |||
| Interest Paid | 8.87M | 7.66M | 2.88M | 1.68M | N/A | |||
| Other non cash items | 27.12M | 27.46M | 17.22M | 13.69M | 15.89M | |||
| OPERATING CASH FLOW | -65.89M | -83.03M | -117.49M | -49.03M | 3.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.98M | -6.57M | -5.50M | -510.00K | -590.00K | |||
| Other Investing Activity | -124.93M | -192.63M | 146.11M | -144.12M | N/A | |||
| INVESTING CASH FLOW | -131.91M | -199.19M | 140.60M | -144.63M | -590.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 75.00M | 10.00M | 20.00M | N/A | |||
| Stock Issued/Repurchased | 142.85M | 115.06M | 120.18M | 74.94M | 320.00K | |||
| Other Financing Activity | N/A | -35.40M | 0.00 | -950.00K | -300.00K | |||
| FINANCING CASH FLOW | 182.45M | 154.66M | 130.18M | 93.99M | 20.00K | |||
| CHANGE IN CASH | -15.36M | -127.57M | 153.29M | -99.67M | 3.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -65.89M | -83.03M | -117.49M | -49.03M | 3.75M | |||
| Capital Expenditure | -6.98M | -6.57M | -5.50M | -510.00K | -590.00K | |||
| FREE CASH FLOW | -72.87M | -89.59M | -123.00M | -49.54M | 3.16M | |||
All data in USD